JPWO2023182507A1 - - Google Patents

Info

Publication number
JPWO2023182507A1
JPWO2023182507A1 JP2024509268A JP2024509268A JPWO2023182507A1 JP WO2023182507 A1 JPWO2023182507 A1 JP WO2023182507A1 JP 2024509268 A JP2024509268 A JP 2024509268A JP 2024509268 A JP2024509268 A JP 2024509268A JP WO2023182507 A1 JPWO2023182507 A1 JP WO2023182507A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024509268A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2023182507A1 publication Critical patent/JPWO2023182507A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2024509268A 2022-03-24 2023-03-24 Pending JPWO2023182507A1 (enrdf_load_stackoverflow)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022049132 2022-03-24
PCT/JP2023/011889 WO2023182507A1 (ja) 2022-03-24 2023-03-24 薬学的組成物、間葉系幹細胞の三次元培養物の製造方法、エクソソームの製造方法、および薬学的組成物の製造方法

Publications (1)

Publication Number Publication Date
JPWO2023182507A1 true JPWO2023182507A1 (enrdf_load_stackoverflow) 2023-09-28

Family

ID=88101723

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024509268A Pending JPWO2023182507A1 (enrdf_load_stackoverflow) 2022-03-24 2023-03-24

Country Status (2)

Country Link
JP (1) JPWO2023182507A1 (enrdf_load_stackoverflow)
WO (1) WO2023182507A1 (enrdf_load_stackoverflow)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011160678A (ja) * 2010-02-05 2011-08-25 Sumitomo Chemical Co Ltd 検体を提供する哺乳動物における肝臓腫瘍性病変の存在を検出するために有効なマイクロｒｎａ
CA3107434C (en) * 2011-08-04 2023-06-06 Yeda Research And Development Co. Ltd. Micro-rnas and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone-associated medical conditions
JP2015529450A (ja) * 2012-07-19 2015-10-08 リニューロン・リミテッドＲｅＮｅｕｒｏｎ Ｌｉｍｉｔｅｄ 幹細胞微粒子
CN113817672A (zh) * 2014-05-18 2021-12-21 儿童医学中心公司 涉及外排体的方法和组合物
IT201600093825A1 (it) * 2016-09-19 2018-03-19 Fondazione St Italiano Tecnologia Composizione farmaceutica di miRNA e suoi usi terapeutici.
JP6830976B2 (ja) * 2019-03-08 2021-02-17 キユーピー株式会社 マイクロｒｎａの発現亢進剤及びマイクロｒｎａ発現亢進用飲食品
WO2021003403A1 (en) * 2019-07-02 2021-01-07 Ohio State Innovation Foundation Neurodegenerative disease therapies utilizing the skin-brain axis
JP6948081B2 (ja) * 2020-02-03 2021-10-13 株式会社フルステム エクソソーム回収方法
CN115245521B (zh) * 2021-04-28 2024-07-26 时比曼生物科技(上海)有限公司 含有干细胞胞外囊泡的滴鼻剂及其在治疗脑神经血管疾病中的应用

Also Published As

Publication number Publication date
WO2023182507A1 (ja) 2023-09-28

Similar Documents

Publication Publication Date Title
BR102023009641A2 (enrdf_load_stackoverflow)
BR102023008688A2 (enrdf_load_stackoverflow)
BR102023007252A2 (enrdf_load_stackoverflow)
JPWO2023182507A1 (enrdf_load_stackoverflow)
BY13173U (enrdf_load_stackoverflow)
BY13171U (enrdf_load_stackoverflow)
CN307050526S (enrdf_load_stackoverflow)
CN307050457S (enrdf_load_stackoverflow)
CN307049561S (enrdf_load_stackoverflow)
CN307049505S (enrdf_load_stackoverflow)
CN307048392S (enrdf_load_stackoverflow)
CN307047954S (enrdf_load_stackoverflow)
CN307047794S (enrdf_load_stackoverflow)
CN307047752S (enrdf_load_stackoverflow)
CN307047650S (enrdf_load_stackoverflow)
CN307047618S (enrdf_load_stackoverflow)
CN307047565S (enrdf_load_stackoverflow)
CN307047560S (enrdf_load_stackoverflow)
CN307047174S (enrdf_load_stackoverflow)
CN307047119S (enrdf_load_stackoverflow)
CN307045080S (enrdf_load_stackoverflow)
CN307044977S (enrdf_load_stackoverflow)
CN307044932S (enrdf_load_stackoverflow)
CN307044904S (enrdf_load_stackoverflow)
BY13172U (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240926

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241003